Epilim and Epilim Chrono (sodium valproate)
Epilim® (sodium valproate) is considered as a treatment for generalised, partial or other epilepsy. It is also indicated for the treatment of manic episodes, maintenance and prophylactic treatment of bipolar disease in patients not responding to or tolerating lithium.
Epilim is available in a wide range of formulations, including oral syrup, injection, enteric-coated tablets, crushable tablets and Chrono® (prolonged-release) tablets, to meet with the patients’ needs.
Valproate Risk Minimization Materials
Regarding the risks associated with valproate in female patients and pregnant women, Sanofi has Valproate Risk Minimization Materials, please click here to download the educational materials. Should you have any enquiry on the valproate risk minimization materials, please contact us for further information.
Reference: Epilim and Epilim Chrono Hong Kong Prescribing Information.
Solian® (amisulpride) is an atypical anti-psychotic drug indicated for treatment of psychoses, particularly acute or chronic schizophrenic disorders, characterised by positive symptoms (e.g. delusion, hallucinations, thought disorders) and/or negative symptoms (e.g. blunted emotions, emotional and social withdrawal), including when the negative symptoms predominate.
Reference: Solian Hong Kong Prescribing Information.
Stilnox® (zolpidem) is indicated for treatment of severe sleep disorders in occasional insomnia and transient insomnia.
Reference: Stilnox Hong Kong Prescribing Information.
Stilnox CR (zolpidem)
Stilnox CR® with double layer structure provides an extended release of zolpidem. Indicated for the short-term treatment of insomnia in adults.
Reference: Stilnox CR Hong Kong Prescribing Information.